Research Ethics and Policy Series (REPS): Jonathan Kimmelman, PhD. "Assessing the Scientific Case for Early Phase Trials and/or Innovative Care: the PATH Approach"
12:00pm - 1:00pm • Hybrid: RCH B102AB, Richards Bldg., 3700 Hamilton Walk (and virtual via Zoom)
Assessing the Scientific Case for Early Phase Trials and/or Innovative Care: the PATH Approach
Jonathan Kimmelman, PhD
Director of Biomedical Ethics unit
mc gill university
Jonathan Kimmelman is a James McGill Professor in the Biomedical Ethics Unit / Social Studies of Medicine. He has cross appointments in Experimental Medicine, Epidemiology, Biostatistics and Occupational Health, and Human Genetics. Kimmelman holds a PhD in Molecular Biophysics and Biochemistry from Yale University, and joined McGill in 2005. His research revolves around the ethical, social and policy dimensions of translational research. He received the Institute of Genetics Maud Menten New Investigator Prize, a CIHR New Investigator Award (2008) and a Friedrich Bessel- Humboldt Award (2014). Kimmelman chaired the ethics committee of the American Society of Gene and Cell Therapy, 2008-2010, and chairs the ethics committee of the International Society of Stem Cell Research.
More details to follow.
Streaming available via Zoom